Research Insights

Single Use Bioprocessing Market Overview The single use bioprocessing market is estimated to be worth $3.4 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 12% during the forecast period. Over time, biologics have gained significant popularity owing to their therapeutic efficacy, favorable safety profiles and ability to treat a wide variety of disease indications, which are otherwise hard to treat. The success of these interventions has prompted the stak

...read more

Dental 3D Printing Market Overview The dental 3D printing market is estimated to be USD 2.9 billion in 2023 and is anticipated to grow at an annualized growth rate (CAGR) of 15.1% during the forecast period 2023-2035. 3D printing, also known as additive manufacturing, is a method of producing 3-dimensional objects layer-by-layer, using a computer aided design. Owing to its ability to print complex models using a wide range of materials, 3D printing has applications across various industries,

...read more

At Home Testing Kits Market The at home testing kits market is estimated to be worth $14.8 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 6% during the forecast period. Since the approval of the first over-the-counter test kits in the early 1976, there has been a substantial increase in the development initiatives focused on such products. In this context, it is worth highlighting that over 20 million at-home pregnancy test kits are being annually sold in t

...read more

Pharmaceutical Contract Manufacturing Market Overview The pharmaceutical contract manufacturing market is estimated to be worth $83 billion in 2022 and is expected to grow at CAGR of 6.6% during the forecast period. At present, the pharmaceutical industry is dominated by the presence of small molecule products, which represent close to 80% of the overall pipeline. Even though biologics have shown significant promise in the treatment of a wide range of disorders, in recent years, approval

...read more

Remote Patient Monitoring Market Overview The remote patient monitoring market is estimated to be worth $10.5 billion in 2021 and is expected to grow at CAGR of 24.5% during the forecast period. In the last few years, there has been an evident rise in the global disease burden. More importantly, the inability to report a health issue to a medical practitioner in its initial stages is expected to cost over USD 90 billion in excess and more than USD 40 billion in productivity loss, each ye

...read more

NGS Kits Market Overview The NGS kits market is estimated to be worth around $1.1 billion in 2021 and is expected to grow to $11.5 billion by 2035. The field of genomic data collection and analysis has evolved significantly since the introduction of a gene sequencing method by Frederick Sanger in 1977. Advances in DNA sequencing technologies have led to significant developments in a variety of healthcare-focused research fields, such as precision medicine and diagnostics. Particularly, t

...read more

Novel Antibody Therapy Market The novel antibody therapy market is estimated to be worth $2.4 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 36% during the forecast period. Cancer is known to be one of the leading causes of deaths, worldwide. In fact, as per the annual statistics reported by the American Cancer Society (ACS) indicate that, in 2022, around 1.9 million individuals are likely to be diagnosed with various types of cancer in the US. Further

...read more

Safety Syringe and Safety Needles Market Overview The safety syringe and safety needles market is estimated to be worth $6.7 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 2.2% during the forecast period. According to a study published in the Canadian Journal of Infectious Disease and Medical Microbiology in 2021, more than 1.3 million cases of needlestick injuries (NSI) among health care workers (HCWs) are reported every year in the US and Europe. NSI

...read more

Global Medical Device Coating Market Overview The global medical device coating market is estimated to be worth USD 7.7 billion in 2023, growing at compounded annual growth rate (CAGR) of 7.7% during the forecast period. According to the World Health Organization (WHO), presently, around two million medical devices are available across the globe. It is also worth highlighting that, since 2020, the Food and Drug Administration (FDA) has approved 125 new medical devices. The growing demand for

...read more

Alzheimer’s Disease Market Overview The Alzheimer’s disease market is estimated to be worth $7.6 billion in 2022 and is expected to grow at CAGR of 12% during the forecast period. Alzheimer’s disease is a progressive neurological disorder characterized by the death of brain cells, eventually leading to memory loss, cognitive dysfunction and dementia. Accounting for 60-70% cases of dementia, Alzheimer’s disease is known to be the sixth leading cause of death in the US.

...read more

ADC Payload / Warheads Market Overview The ADC payload / warheads market is estimated to be worth $267 million in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 12% during the forecast period. With six approved drugs, namely POLIVY™ (2019), LUMOXITI™ (2018), BESPONSA® (2017), MYLOTARG™ (2017, reapproval), KADCYLA® (2013) and ADCETRIS® (2011), and more than 300 candidates in the pipeline (clinical / preclinical stages), antibody drug

...read more

Single Use Sensors Market Overview The single use sensors market for bioprocessing is estimated to be worth $280 million in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 15% during the forecast period. With several blockbuster drugs in the market and numerous others in the development pipeline, the modern biopharmaceutical industry is poised to grow at a significant pace over the coming years. The success of biopharmaceutical drugs has necessitated an upgrade of

...read more

In Vitro Diagnostics Market Overview 2023-2035 The global in vitro diagnostics market refers to the market for medical devices and laboratory procedures used to analyze human specimens, such as blood, urine, and tissue, to diagnose diseases, monitor treatment, and assess health status. In vitro diagnostics are tests conducted on samples such as blood or tissue taken from the human body. These tests can detect diseases, conditions, and infections, and are used to monitor a person’s ov

...read more

Biosensors Market Overview The biosensors market for drug discovery and development is estimated to be worth $5.0 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9.0% during the forecast period. The drug discovery process, which involves the identification of a relevant biological target and a corresponding pharmacological lead, is deemed crucial to the clinical success of a drug candidate. However, considering the growing complexity of modern pharmacol

...read more

Global Pharmaceutical Vials Market Overview The pharmaceutical vials market is estimated to be worth $10.1 billion in 2022 and is expected to grow at CAGR of 6% during the forecast period. Over the years, advances in drug / therapy development processes have led the pharmaceutical industry to gradually shift from a one-drug treats all model to a more personalized approach of treatment. The growing complexity of modern pharmacological interventions, such as monoclonal antibodies, and cell

...read more

Aseptic Fill Finish Manufacturing Market Overview The aseptic fill finish manufacturing market is estimated to be worth USD 5.4 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9%, during the forecast period. Aseptic fill finish refers to accurate and sterile fill finish / sealing of drug products into packaging containers, such as vials, prefilled syringes, ampoules and cartridges. These aseptic conditions during fill-finish operations are not only esse

...read more

T Cell Recepter Market Overview  The TCR therapy market is estimated to be worth $0.03 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 51% during the forecast period, mainly driven by the need for targeted cancer treatment for solid tumors. Modified T-cell receptor (TCR) based therapy is an emerging class of adoptive cell therapy that employs genetically modified lymphocytes to target specific tumor markers. Their tumor cell killing efficacy may be prim

...read more

Digital Pathology Market Overview The digital pathology market is estimated to be worth $0.7 billion in 2022 and is expected to grow at a CAGR of 8.3% during the forecast period. Pathology is a subfield of medical science that primarily focuses on the nature, genesis and cause of a disease. Further, pathology forms an essential component of diagnostic pathways established for multiple disease indications, especially cancer detection. In fact, 70-80% of the total healthcare decisions invo

...read more

Deep Learning Market Overview The deep learning market (for healthcare and drug discovery) is estimated to be $34.5 billion in 2023 and is expected to grow at a CAGR of 21.9% during the forecast period. Since the mid-twentieth century, computing devices have continually been explored for applications beyond mere calculations, to emerge as machines that possess intelligence. These targeted efforts have led to the emergence of artificial intelligence, the next-generation simulator that emplo

...read more
  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry